Header Logo

Connection

Sarah Hughes to Clinical Trials as Topic

This is a "connection" page, showing publications Sarah Hughes has written about Clinical Trials as Topic.
Connection Strength

1.192
  1. Hughes S, Wells K, McSorley P, Freeman A. Preparing individual patient data from clinical trials for sharing: the GlaxoSmithKline approach. Pharm Stat. 2014 May-Jun; 13(3):179-83.
    View in: PubMed
    Score: 0.358
  2. Hughes S, Harris J, Flack N, Cuffe RL. The statistician's role in the prevention of missing data. Pharm Stat. 2012 Sep-Oct; 11(5):410-6.
    View in: PubMed
    Score: 0.318
  3. Hughes S, Cuffe RL, Lieftucht A, Garrett Nichols W. Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial. Pharm Stat. 2009 Jan-Mar; 8(1):25-37.
    View in: PubMed
    Score: 0.249
  4. Hughes S, Hughes A, Brothers C, Spreen W, Thorborn D. PREDICT-1 (CNA106030): the first powered, prospective trial of pharmacogenetic screening to reduce drug adverse events. Pharm Stat. 2008 Apr-Jun; 7(2):121-9.
    View in: PubMed
    Score: 0.236
  5. Brothers CH, Hernandez JE, Cutrell AG, Curtis L, Ait-Khaled M, Bowlin SJ, Hughes SH, Yeo JM, Lapierre DH. Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects. J Acquir Immune Defic Syndr. 2009 May 01; 51(1):20-8.
    View in: PubMed
    Score: 0.016
  6. Carroll K, Ross HC, Evans D, France L, Hemmings R, Hughes S, Lynn F, Mahoney P, Phillips A. Conditional approval: discussion points from the PSI conditional approval expert group. Pharm Stat. 2008 Oct-Dec; 7(4):263-9; discussion 270-1.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.